Virttu Biologics (United Kingdom)

Institution (Company)

Homepage ROR

Also Known As

Virttu Biologics (United Kingdom)

Publications

1.8K

Citations

Authors

Concepts

About

Virttu Biologics (United Kingdom) is a company institution in Glasgow, United Kingdom known for immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	14	398
2	Immunology	5	14	398
3	Cell Biology	3	8	104
4	Pathology	2	5	69
5	Hepatology	1	4	40

Virttu Biologics (United Kingdom)

Publications

1.8K

Citations

Page 1

	Year	Citations
Ten Years of Global Evolution of the Human Respiratory Syncytial Virus BA Genotype with a 60-Nucleotide Duplication in the G Protein Gene Alfonsina Trento, Inmaculada Casas, Ana Calderón, Journal of Virology	2010	180
Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting Munitta Muthana, Aneurin J. Kennerley, Russell Hughes, Nature Communications	2015	161
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients Keri A. Streby, James I. Geller, Mark A. Currier, Clinical Cancer Research	2017	136
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models Chun‐Yu Chen, Pin-Yi Wang, Brian Hutzen, Scientific Reports	2017	86
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial Keri A. Streby, Mark A. Currier, Melinda Triplet, Molecular Therapy	2019	59
Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716 Sarah Danson, Joe Conner, John Edwards, Lung Cancer Phase I/iia TrialCancer-associated VirusIntrapleural AdministrationImmunologyOncolytic Herpesvirus Therapy	2020	53
TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma Brian Hutzen, Chun‐Yu Chen, Pin-Yi Wang, Molecular Therapy — Oncolytics	2017	39
Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors Amy Kwan, Natalie Winder, Emer Atkinson, Molecular Cancer Therapeutics	2020	36
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion Julia Cockle, Anke Brüning‐Richardson, Karen J. Scott, Molecular Therapy — Oncolytics	2017	33
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation Mark A. Currier, Les Sprague, Tilat A. Rizvi, Oncotarget	2017	30

Page 1